Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Taekyu | - |
dc.contributor.author | Christov, Plamen P. | - |
dc.contributor.author | Shaw, Subrata | - |
dc.contributor.author | Tarr, James C. | - |
dc.contributor.author | Zhao, Bin | - |
dc.contributor.author | Veerasamy, Nagarathanam | - |
dc.contributor.author | Jeon, Kyu Ok | - |
dc.contributor.author | Mills, Jonathan J. | - |
dc.contributor.author | Bian, Zhiguo | - |
dc.contributor.author | Sensintaffar, John L. | - |
dc.contributor.author | Arnold, Allison L. | - |
dc.contributor.author | Fogarty, Stuart A. | - |
dc.contributor.author | Perry, Evan | - |
dc.contributor.author | Ramsey, Haley E. | - |
dc.contributor.author | Cook, Rebecca S. | - |
dc.contributor.author | Hollingshead, Melinda | - |
dc.contributor.author | Millin, Myrtle Davis | - |
dc.contributor.author | Lee, Kyung min | - |
dc.contributor.author | Koss, Brian | - |
dc.contributor.author | Budhraja, Amit | - |
dc.contributor.author | Opferman, Joseph T. | - |
dc.contributor.author | Kim, Kwangho | - |
dc.contributor.author | Arteaga, Carlos L. | - |
dc.contributor.author | Moore, William J. | - |
dc.contributor.author | Olejniczak, Edward T. | - |
dc.contributor.author | Savona, Michael R. | - |
dc.contributor.author | Fesik, Stephen W. | - |
dc.date.accessioned | 2022-07-09T19:22:43Z | - |
dc.date.available | 2022-07-09T19:22:43Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2019-04 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/147970 | - |
dc.description.abstract | Overexpression of myeloid cell leukemia-1 (Mcl-1) in cancers correlates with high tumor grade and poor survival. Additionally, Mcl-1 drives intrinsic and acquired resistance to many cancer therapeutics, including B cell lymphoma 2 family inhibitors, proteasome inhibitors, and antitubulins. Therefore, Mcl-1 inhibition could serve as a strategy to target cancers that require Mcl-1 to evade apoptosis. Herein, we describe the use of structure-based design to discover a novel compound (42) that robustly and specifically inhibits Mcl-1 in cell culture and animal xenograft models. Compound 42 binds to Mcl-1 with picomolar affinity and inhibited growth of Mcl-1-dependent tumor cell lines in the nanomolar range. Compound 42 also inhibited the growth of hematological and triple negative breast cancer xenografts at well tolerated doses. These findings highlight the use of structure-based design to identify small molecule Mcl-1 inhibitors and support the use of 42 as a potential treatment strategy to block Mcl-1 activity and induce apoptosis in Mcl-1-dependent cancers. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.title | Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kyung min | - |
dc.identifier.doi | 10.1021/acs.jmedchem.8b01991 | - |
dc.identifier.scopusid | 2-s2.0-85064991352 | - |
dc.identifier.wosid | 000466053900011 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.62, no.8, pp.3971 - 3988 | - |
dc.relation.isPartOf | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 62 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 3971 | - |
dc.citation.endPage | 3988 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | FRAGMENT-BASED METHODS | - |
dc.subject.keywordPlus | BCL-2 FAMILY | - |
dc.subject.keywordPlus | IMMUNOHISTOCHEMICAL ANALYSIS | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | BAX | - |
dc.subject.keywordPlus | BH3-MIMETICS | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordPlus | NAVITOCLAX | - |
dc.identifier.url | https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01991 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.